Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

9476	Companies
185464	Keywords
117811	Articles
99314	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 08/04/2025 at 22:10, 4 months ago

Onco-Innovations Sets Course for Human Trials with Avance Clinical Agreement

Clinical Trial Onco-Innovations PNKP Inhibitor Avance Clinical Regulatory Preparations
PRESS RELEASE

published on 08/04/2025 at 22:05, 4 months ago

Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement
Onco-Innovations partners with Avance Clinical for regulatory and clinical documentation for their PNKP inhibitor therapy. Collaboration aims to advance cancer trials

Clinical Trials Cancer Research Onco-Innovations Regulatory Support Avance Clinical
BRIEF

published on 07/31/2025 at 00:05, 4 months 5 days ago

Inka Health to Lead AI-Driven Oncology Project with OneMedNet

Clinical Trials Oncology Health Innovation Real-world Data AI Analytics
PRESS RELEASE

published on 07/31/2025 at 00:00, 4 months 5 days ago

Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
Onco-Innovations Limited's subsidiary, Inka Health Corp., selected by OneMedNet Corporation for data analytics initiative to improve cancer therapy processes and accelerate market entry for new therapies

Real-world Evidence Cancer Therapies Onco-Innovations Limited Inka Health Corp. OneMedNet Corporation
BRIEF

published on 07/30/2025 at 03:35, 4 months 6 days ago

Onco-Innovations Limited Announces Non-Brokered Private Placement

Private Placement Research And Development Regulatory Approvals Shares And Warrants Onco-Innovations
PRESS RELEASE

published on 07/30/2025 at 03:30, 4 months 6 days ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 243,903 units at $1.64 per unit for proceeds of $400,000. Additionally, incentive stock options and restricted share units are granted. Company focuses on cancer research and treatment

Private Placement Incentive Stock Options Cancer Research Restricted Share Units Onco-Innovations Limited
BRIEF

published on 07/21/2025 at 06:05, 4 months 15 days ago

Onco-Innovations Welcomes Dr. Dennis Hall to Advisory Board

Cancer Research Onco-Innovations PNKP Inhibitor Dennis Hall Precision Therapies
PRESS RELEASE

published on 07/21/2025 at 06:00, 4 months 15 days ago

Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
Onco-Innovations Limited appoints Dr. Dennis Hall, renowned chemist, to Scientific and Clinical Advisory Board. Dr. Hall brings expertise in boron chemistry, catalysis, and drug discovery to advance innovative oncology-focused therapies

Scientific Advisory Board Oncology Onco-Innovations Limited Dr. Dennis Hall Boron Chemistry
BRIEF

published on 07/12/2025 at 00:05, 4 months 24 days ago

Onco-Innovations Partners with Redwood AI for PNKP Inhibitor Development

Cancer Treatment Drug Development Onco-Innovations PNKP Inhibitor Redwood AI
PRESS RELEASE

published on 07/12/2025 at 00:00, 4 months 24 days ago

Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
Onco-Innovations partners with Redwood AI for drug development, leveraging AI-driven chemistry tools to enhance cancer therapy with PNKP Compound. Vancouver-based collaboration aims to improve research efficiency

Cancer Therapy Onco-Innovations PNKP Compound Redwood AI AI-driven Chemistry

Accesswire

Published on 12/05/2025 at 14:00, 18 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 18 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 43 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 11 hours 48 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 18 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:45, 33 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 18 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 1 hour 18 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 2 hours 13 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 2 hours 18 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre

Les Echos

Published on 12/05/2025 at 08:45, 5 hours 33 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 18 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 20 hours 33 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 20 hours 34 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE